Viagra statistics in 2001 (US)

Figures in million

Current Users
Dropouts
Never Tried Beforea

3million
6.5 million
20.5 million

2000
10,862.20
5,246.80
2,018.50
539.10
3,057.80

1999
9,912.90
4,541.20
1,783.60
867.10
2,721.00

SGA (% ge of Sales)
R & D (% ge of Sales)
Other Expenses (% ge of Sales)

2000
48.30%
18.58%
4.96%

1999
45.81%
17.99%
8.75%

Net Sales in 2002

Less:SGA (45.68%)
Less:R & D (17.34%)
Less:Other Expenses (10.21%)
Net Income (2002= 27.98%)

2002
13432.8
6136.1
2329.25
2153.27
3758.49

Net Sales
SGA
R&D
Other Expenses
Net Income

Revenue
US

UK
Brazil
Germany
Mexico
Italy
Canda
France
Spain

$2,051.70

1998
9,236.80
4,397.20
1,738.90
1,000.28
2,097.90
1,998.00
47.61%
18.83%
10.83% *

Allocation of Marketing Expense

$177.86

Revenue %ge of Intl. Rev (P)

p * 266.79
$94.35
18.18%
$48.51
$84.81
16.34%
$43.61
$81.56
15.72%
$41.94
$65.84
12.69%
$33.85
$63.60
12.26%
$32.70
$59.68
11.50%
$30.68
$37.43
7.21%
$19.24
$31.64
6.10%
$16.27
$518.89

1997
8,517.60
3,696.40
1,382.00
3,054.10
-385.1
1997
43.40%
16.23%

1996
7,346.60
3,181.40
1,189.50
1,452.20
1,523.50
1996 Avg % ge
43.30%
45.68%
16.19%
17.34%
11.53%
9.00%

Years
Net Sales
SGA
R&D
Other Expenses
Net
1996
7,346.60
3,181.40 1,189.50
1,452.20
1997
8,517.60
3,696.40 1,382.00
3,054.10
1998
9,236.80
4,397.20 1,738.90
1,000.28
1999
9,912.90
4,541.20 1,783.60
867.10
2000 10,862.20
5,246.80 2,018.50
539.10

Income
1,523.50
-385.1
2,097.90
2,721.00
3,057.80